Market Context — Why This Technology, Why Now

The push for circular economies and stringent environmental regulations worldwide is driving industries to seek cleaner manufacturing processes. Simultaneously, the rapid evolution of electric vehicles, 5G/6G infrastructure, and advanced medical devices demands materials with unprecedented performance characteristics. This technology directly addresses these dual pressures by offering a sustainable pathway to produce high-value cyclic polymers, enabling companies to meet both environmental targets and performance benchmarks while reducing reliance on scarce resources and complex supply chains.

Key Competitive Advantages
01

Reduces manufacturing energy consumption and CO2 emissions by up to 50% through a photopolymerization process that minimizes heat and harmful catalysts.

02

Enables high-precision cyclic structure control, stably synthesizing uniform, high-purity cyclic polymers previously difficult to achieve with conventional methods.

03

Applies to a wide range of monomers with ethylenically unsaturated bonds, enabling the creation of diverse functional cyclic polymers and expanding product portfolios.

Market Opportunity
Automotive Lightweight Materials
$3B–$4B globally (AI est.)
With the advancement of EVs, lightweighting vehicle bodies and components is an urgent challenge. High-strength, high-heat-resistant cyclic polymers produced by this technology could see increased demand as metal replacement materials.
Automotive component manufacturers EV battery housing suppliers Advanced composites producers
Electronics Materials
$2B–$3B globally (AI est.)
High-performance 5G/6G and AI-related devices require low-dielectric, high-heat-resistant substrate and encapsulation materials. This technology could provide cyclic polymers that meet these demands.
Semiconductor packaging companies Advanced PCB manufacturers Display panel material suppliers
Medical and Healthcare Materials
$1.5B–$2.5B globally (AI est.)
Cyclic polymers with excellent biocompatibility, drug sustained-release properties, and sterilization resistance could create new value in implants, drug carriers, and medical device fields.
Medical device manufacturers Pharmaceutical delivery system developers Biomedical implant companies
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a broad scope, covering the manufacturing method for cyclic polymers, the resulting cyclic polymers, and the specific photoinitiators used in their synthesis. Its validity was rigorously established through successful responses to examiner objections against four prior art documents, indicating a robust and difficult-to-invalidate right.

Competitive White Space

This patent primarily covers the synthesis method and specific photoinitiators for cyclic polymers. Licensees could develop additional IP around novel applications, specific material formulations for niche markets, or advanced integration techniques into existing manufacturing lines.

Economic Impact
~$1.0M/year estimated manufacturing cost reduction potential per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Implementing this technology could reduce electricity consumption by ~20% compared to conventional thermal polymerization. Eliminating special catalysts and reducing by-products could cut raw material and waste disposal costs by ~15% each. For a production line with an annual output of 1,000 tons and current manufacturing costs of ~$3.5M/year (AI est.), this translates to a direct cost reduction of (~$3.5M × 20% + ~$3.5M × 15% + ~$3.5M × 15%) = ~$1.5M/year (AI est.). Including reduced opportunity loss from shorter manufacturing times and improved yield, the total economic impact could exceed ~$1.0M/year (AI est.).

Speed to Market
6× faster than in-house development
This technology is already patented as a foundational method for cyclic polymer manufacturing, based on the proven principle of photopolymerization. This could significantly shorten R&D periods compared to a licensee developing similar technology from scratch. Specifically, the synthesis method for cyclic polymers and the photoinitiator used are clearly defined, reducing technical uncertainty and making application to existing photopolymerization equipment and related technologies relatively easy. This is estimated to shorten the lead time to market by approximately 2.5 years.
Competitive Positioning

X: Manufacturing Efficiency & Low Environmental Impact
Y: Material Functionality & Structure Control

Business Models & Applications
🤝 Technology Licensing
License the patent for this manufacturing method and photoinitiator, enabling licensees to integrate cyclic polymer production into their product development.
🔬 Joint Research & Development
Collaborate with licensees to optimize cyclic polymer compositions and manufacturing processes for specific applications, accelerating new product development.
📦 Functional Material Supply
Supply high-performance cyclic polymers, manufactured using this technology, as intermediate materials to licensees for integration into their final products.
Adjacent Application Opportunities
🔬 Medical & Biotech
Biocompatible Cyclic Polymers for Healthcare
Cyclic polymers synthesized with this technology could be engineered for biocompatibility, offering potential applications as carriers in drug delivery systems (DDS), biodegradable implant materials, or scaffolds for regenerative medicine, addressing a global market projected to reach ~$100B by 2030 (AI est.).
🔋 Energy
Next-Generation Battery Materials
High-heat-resistant and stable cyclic polymers could be utilized as separators or electrolyte binders in lithium-ion batteries, potentially enhancing battery safety and extending lifespan by 15-20% compared to current materials.
🎨 Coatings & Adhesives
High-Durability Coatings and Adhesives
Paints and adhesives formulated with cyclic polymers from this technology could significantly improve abrasion resistance, chemical resistance, and weatherability compared to conventional materials, potentially extending product lifespan by over 30% in harsh environments.
Integration Roadmap — Estimated 18-Month Deployment
Phase 1: Technology Evaluation & PoC
Duration: 3 months
Evaluate the core principles of this technology and its compatibility with a licensee's existing equipment and materials. Conduct small-scale lab-level Proof of Concept (PoC) and establish initial manufacturing conditions.
Phase 2: Prototype Development & Optimization
Duration: 9 months
Based on PoC results, develop cyclic polymer prototypes tailored to the licensee's product requirements. Optimize the manufacturing process and conduct quality evaluations.
Phase 3: Mass Production & Market Launch
Duration: 6 months
Establish mass production capabilities using the optimized process. Address relevant regulatory compliance and execute product rollout and sales strategies for target markets.
Technical Feasibility
This technology defines a method for producing cyclic polymers using ethylenically unsaturated monomers and specific photoinitiators via light irradiation, making it readily applicable to existing photopolymerization and UV curing equipment. The patent claims clearly specify the composition of the compound represented by General Formula (1), and its synthesis route is established, suggesting high technical reproducibility. This could enable relatively rapid integration into existing production lines without significant capital investment.
Success Scenario
If adopted, this technology could reduce manufacturing energy costs by up to 20% compared to conventional processes, enhancing product price competitiveness and potentially expanding market share. Furthermore, high-precision cyclic structure control could enable rapid market introduction of high-performance polymer products previously difficult to develop, opening new business areas and boosting brand value.
Patent Record
APPLICATION NO.
特願2020-168121
REGISTRATION NO.
7551083
FILING DATE
2020/10/02
GRANT DATE
2024/09/06
EXPIRATION DATE
2040/10/02
PATENT HOLDER
学校法人神奈川大学
Examination History
2023年08月24日
出願審査請求書
2024年06月04日
拒絶理由通知書
2024年07月06日
手続補正書(自発・内容)
2024年07月06日
意見書
2024年08月27日
特許査定